Liberty Wealth Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.4K | Hold |
22,666
| – | – | ﹤0.01% | 229 |
|
|
2025
Q1 | $28.6K | Hold |
22,666
| – | – | 0.01% | 153 |
|
|
2024
Q4 | $51.5K | Sell |
22,666
-11
| -0% | -$25 | 0.01% | 213 |
|
|
2024
Q3 | $78K | Hold |
22,677
| – | – | 0.01% | 211 |
|
|
2024
Q2 | $115K | Hold |
22,677
| – | – | 0.02% | 201 |
|
|
2024
Q1 | $192K | Hold |
22,677
| – | – | 0.04% | 181 |
|
|
2023
Q4 | $94K | Sell |
22,677
-831
| -4% | -$3.45K | 0.02% | 168 |
|
|
2023
Q3 | $71K | Buy |
23,508
+13,471
| +134% | +$40.7K | 0.02% | 172 |
|
|
2023
Q2 | $310K | Buy |
10,037
+10
| +0.1% | +$309 | 0.08% | 132 |
|
|
2023
Q1 | $496K | Buy |
+10,027
| New | +$496K | 0.1% | 128 |
|
|
2022
Q3 | $176K | Buy |
2,667
+667
| +33% | +$44K | 0.05% | 142 |
|
|
2022
Q2 | $82K | Buy |
+2,000
| New | +$82K | 0.03% | 148 |
|